Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgan

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|June 26, 2023
Discovery of pyrrolo[2,1-<i>f</i>][1,2,4]triazine-based inhibitors of adaptor protein 2-associated kinase 1 for the treatment of painCarolyn D Dzierba, Bireshwar Dasgupta, George Karageorge, et al.
Journal of Medicinal Chemistry|December 14, 2016
Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity RelationshipJames Cook, F Christopher Zusi, Ivar M McDonald, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|June 26, 2023
Discovery of pyrrolo[2,1-<i>f</i>][1,2,4]triazine-based inhibitors of adaptor protein 2-associated kinase 1 for the treatment of painCarolyn D Dzierba, Bireshwar Dasgupta, George Karageorge, et al.
Journal of Medicinal Chemistry|December 14, 2016
Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity RelationshipJames Cook, F Christopher Zusi, Ivar M McDonald, et al.
Pageof 6